Kuhlmann Shirley R. 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Kuhlmann Shirley R.
EVP and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-01-10$21.34/sh+27,500$586,850→ 146,684 total - Sale
Common Stock
2025-01-10$32.87/sh−21,400$703,407→ 125,284 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-01-10−27,500→ 0 totalExercise: $21.34Exp: 2030-02-05→ Common Stock (27,500 underlying) - Sale
Common Stock
2025-01-10$33.64/sh−6,100$205,220→ 119,184 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.43 to $33.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.42 to $33.41, inclusive.
- [F4]The option is fully vested and exercisable.